Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash & Current Investments (2018 - 2025)

Outset Medical (OM) has disclosed Cash & Current Investments for 7 consecutive years, with $306.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 93.3% to $306.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $306.7 million, a 93.3% increase, with the full-year FY2025 number at $306.7 million, up 93.3% from a year prior.
  • Cash & Current Investments was $306.7 million for Q4 2025 at Outset Medical, up from $142.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $429.5 million in Q2 2021 to a low of $35.5 million in Q1 2024.
  • A 5-year average of $228.0 million and a median of $249.2 million in 2023 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: plummeted 87.68% in 2023, then skyrocketed 218.47% in 2025.
  • Outset Medical's Cash & Current Investments stood at $372.8 million in 2021, then decreased by 21.99% to $290.8 million in 2022, then decreased by 28.94% to $206.7 million in 2023, then decreased by 23.21% to $158.7 million in 2024, then skyrocketed by 93.3% to $306.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash & Current Investments are $306.7 million (Q4 2025), $142.2 million (Q3 2025), and $113.1 million (Q1 2025).